- Home
- GOOD vs IVA Comparison
GOOD vs IVA Comparison
Compare GOOD & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOOD | IVA |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.9M | 737.1M |
| IPO Year | 2003 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GOOD | IVA |
|---|---|---|
| Price | $12.02 | $3.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | $14.13 | ★ $15.20 |
| AVG Volume (30 Days) | 468.1K | ★ 2.9M |
| Earning Date | 11-03-2026 | 09-28-2026 |
| Dividend Yield | ★ 10.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $161,336,000.00 | N/A |
| Revenue This Year | $5.94 | N/A |
| Revenue Next Year | $3.02 | N/A |
| P/E Ratio | $66.53 | ★ N/A |
| Revenue Growth | ★ 8.00 | N/A |
| 52 Week Low | $10.33 | $2.82 |
| 52 Week High | $13.28 | $7.98 |
Technical Indicators
Market Signals| Indicator | GOOD | IVA |
|---|---|---|
| Relative Strength Index (RSI) | 38.69 | 56.06 |
| Support Level | $11.15 | $3.23 |
| Resistance Level | $13.07 | $3.76 |
| Average True Range (ATR) | 0.32 | 0.24 |
| MACD | -0.08 | 0.10 |
| Stochastic Oscillator | 28.98 | 93.62 |
Price Performance
Historical ComparisonAbout GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.